TVTX SCHEDULE 13G/A: SEC filing
An institutional investor
Filed with the SEC on · accession 0000315066-26-002862
TVTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
An institutional investor filed an amended Schedule 13G disclosing a passive ownership position in Travere Therapeutics, Inc. The filing indicates a change in the holder's previously reported stake.
Key details
✦ Ask GOAX AI about this filing — what it means for TVTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TVTX?
Click hereFrequently asked questions
What did TVTX file with the SEC on Nov 5, 2026?
TVTX filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G disclosing a passive ownership position in Travere Therapeutics, Inc. The filing indicates a change in the holder's previously reported stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other TVTX SEC filings
Get alerts when TVTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days